# Co-resistance between oral antibiotics for pyelonephritis and those for cystitis—applying an escalation antibiogram model to local community data

**Authors:** Philip Williams, Edward Barton, Ranjeet Bhamber, Léo Gorman, Andrew W Dowsey, Matthew B Avison

PMC · DOI: 10.1093/jacamr/dlaf204 · JAC-Antimicrobial Resistance · 2025-11-10

## TL;DR

This study uses local community data to model how resistance to antibiotics for bladder infections affects choices for kidney infection treatments.

## Contribution

The novel application of an escalation antibiogram with Bayesian modeling to community-level resistance data informs antibiotic choices for pyelonephritis.

## Key findings

- Resistance to cystitis antibiotics significantly increases resistance probabilities for pyelonephritis antibiotics.
- Amoxicillin/clavulanate resistance exceeds 50% when pivmecillinam resistance is presumed.
- Optimal pyelonephritis antibiotics depend on patient age and infection history when resistance to nitrofurantoin or trimethoprim is assumed.

## Abstract

We applied an escalation antibiogram to community urine data to assess how presumptive resistance to first-line antibiotics for cystitis affects resistance to antibiotics used to treat pyelonephritis.

We extracted susceptibility data from Escherichia coli isolates grown from urine samples from general practice during a 5 year period (2019–2023) in a region served by three NHS hospital trusts. Female patients over 18 years old were included, giving a total of 130 514 isolates. We applied a Bayesian model to estimate antibiotic resistance rates for oral pyelonephritis antibiotics, when presuming resistance to each of the first-line antibiotics used for cystitis. The model estimates the probability of resistance with 95% credible intervals and was applied to a variety of patient groups based on age and history of recurrent urinary tract infections.

Resistance to cystitis antibiotics has a marked effect on the probability of resistance to oral antibiotics used to treat pyelonephritis. In particular, amoxicillin/clavulanate should be avoided for pyelonephritis if resistance to pivmecillinam is presumed, because predicted resistance rates exceed 50%. For patients with presumed resistance to nitrofurantoin or trimethoprim, the optimal pyelonephritis antibiotic depends on both age group and history of past infections.

Analysis using an escalation antibiogram informed by our Bayesian model is a useful tool to support empirical antibiotic prescribing for pyelonephritis. It provides an estimate of local resistance rates and a comparison of antibiotic options with a measure of the uncertainty in the data.

## Linked entities

- **Chemicals:** amoxicillin/clavulanate (PubChem CID 6435924), pivmecillinam (PubChem CID 115163), nitrofurantoin (PubChem CID 6604200), trimethoprim (PubChem CID 5578)
- **Diseases:** pyelonephritis (MONDO:0006939), cystitis (MONDO:0006032)
- **Species:** Escherichia coli (taxon 562)

## Full-text entities

- **Diseases:** infections (MESH:D007239), cystitis (MESH:D003556), urinary tract infections (MESH:D014552), pyelonephritis (MESH:D011704)
- **Chemicals:** trimethoprim (MESH:D014295), nitrofurantoin (MESH:D009582), pivmecillinam (MESH:D000561), amoxicillin/clavulanate (MESH:D019980)
- **Species:** Homo sapiens (human, species) [taxon 9606], Escherichia coli (E. coli, species) [taxon 562]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12599318/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12599318/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12599318/full.md

---
Source: https://tomesphere.com/paper/PMC12599318